| Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8+PD‐1− tumor‐infiltrating T cells in PD‐L1‐enriched tumor microenvironment IR Eissa, N Mukoyama, M Abdelmoneim, Y Naoe, S Matsumura, ... International journal of cancer 149 (1), 214-227, 2021 | 12 | 2021 |
| Etiology and pathology of epidemic outbreaks of avian influenza H5N1 infection in Egyptian chicken farms A Ali, G Elmowalid, M Abdel-Glil, T Sharafeldin, F Abdallah, S Mansour, ... Polish Journal of Veterinary Sciences, 2015 | 12 | 2015 |
| Anti-Inflammatory and immunomodulatory role of bone marrow-derived MSCs in mice with acute lung injury M Abdelmoneim, ESY El-Naenaeey, SH Abd-Allah, AA Gharib, ... Journal of Interferon & Cytokine Research 41 (1), 29-36, 2021 | 9 | 2021 |
| C-REV retains high infectivity regardless of the expression levels of cGAS and STING in cultured pancreatic cancer cells D Morimoto, S Matsumura, I Bustos-Villalobos, PA Sibal, T Ichinose, ... Cells 10 (6), 1502, 2021 | 7 | 2021 |
| The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies M Abdelmoneim, MA Aboalela, Y Naoe, S Matsumura, IR Eissa, ... International Journal of Molecular Sciences 24 (17), 13353, 2023 | 4 | 2023 |
| Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model M Abdelmoneim, IR Eissa, MA Aboalela, Y Naoe, S Matsumura, PA Sibal, ... Scientific Reports 12 (1), 21570, 2022 | 4 | 2022 |
| Pathological and molecular detection of a rare case of cutaneous cryptococcosis in a 9-year-old horse A Ali, B Ahmed, N AlGabri, M Abdelmoneim, M Gomaa, ... Comparative Clinical Pathology 29, 883-886, 2020 | 3 | 2020 |
| S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model N Miyajima, IR Eissa, M Abdelmoneim, Y Naoe, T Ichinose, S Matsumura, ... Nagoya Journal of Medical Science 83 (4), 683, 2021 | 2 | 2021 |
| STING activator 2′ 3′‐cGAMP enhanced HSV‐1‐based oncolytic viral therapy PA Sibal, S Matsumura, T Ichinose, I Bustos‐Villalobos, D Morimoto, ... Molecular Oncology 18 (2), 1-19, 2024 | 1 | 2024 |
| Oncolytic herpes simplex virus HF10 (canerpaturev, C-REV) promotes accumulation of CD8+ PD-1-tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment IR Eissa, N Mukoyama, M Abdelmoneim, Y Naoe, S Matsumura, ... International journal of cancer, 2021 | 1 | 2021 |
| Chimeric target factor receptor H Kasuya, Y Naoe, S Matsumura, IRN Eissa, MAAALI MOHAMED US Patent App. 18/272,430, 2024 | | 2024 |
| Chimeric target factor receptor H Kasuya, Y Naoe, S Matsumura, IRN EISSA, MAAALI MOHAMED | | 2023 |
| Abstract: Novel new cell therapy of chimeric antigen receptors into dendritic cells Y Naoe, M Abdelmoneim, MA Aboalela, IR Eissa, S Matsumura, H Kasuya CANCER SCIENCE 114, 997-997, 2023 | | 2023 |
| Abstract: Novel armed oncolytic HSV exhibits strong antitumor effects that lead to complete tumor regression M Abdelmoneim, Y Naoe, IR Eissa, MA Aboalela, S Matsumura, ... CANCER SCIENCE 114, 1855-1855, 2023 | | 2023 |
| Abstract: Oncolytic HSV HF10 (canerpaturev, C-REV) promotes accumulation of CD8+ PD-1-tumor-infiltrating T cells in a SCC model M Abdelmoneim, IR Eissa, N Mukoyama, Y Naoe, S Matsumura, ... CANCER SCIENCE 113, 526-526, 2022 | | 2022 |
Ibrahim R EissaPostdoc Research Fellow at MGH- Harvard medical SchoolVerified email at mgh.harvard.edu
